Trusting a Covid-19 Vaccine: What’s Next? --On line discussion Friday, April 9, 1 PM ET

The CSIS Global Health Policy Center invites you to join us for an online event:
 

Trusting a Covid-19 Vaccine:
What’s Next? 

 

Friday, April 9, 2021

1:00 p.m. to 2:00 p.m. EDT

 

 Join the discussion here → 
 

 

A conversation with

Bruce Gellin

President of Global Immunization
Sabin Vaccine Institute
 

Margaret “Peggy” Hamburg

Former Commissioner, U.S. Food and Drug Administration
Interim Vice President of Global Biological Policy and Programs
Nuclear Threat Initiative
 

Juliette Kayyem

Senior Belfer Lecturer in International Security
Harvard Kennedy School of Government
 

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Description and graphics showing how coronavirus variants have spread in the U.S.

Administration does not grant Michigan's request for additional vaccines to counter coronavisus surge

WASHINGTON — Amid Michigan’s worst-in-the-nation coronavirus surge, scientists and public health officials are urging the Biden administration to flood the state with additional vaccine doses.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Is the U.S. heading toward California, which has America's best COVID numbers, or Michigan, which has the worst?

Colorado shuts a vaccination site after 11 'adverse reactions' to Johnson & Johnson shots, plus other developments

U.S. allotting 85% less J&J vaccines to states next week, following factory problems

Scientists call for new probe into COVID-19 origins: with or without China

Moderna’s COVID-19 vaccine provides antibodies for at least 6 months after the second dose but fades for older persons

Antibodies persisted 6 months after the second dose of Moderna's COVID-19 vaccine in younger and middle-age adults, but were diminished in older adults when using more sensitive assays, according to data from an ongoing phase I trial.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

CDC Says More Virulent British Variant Of Coronavirus Now Dominant In U.S.

A more easily spread coronavirus variant first identified in England last year has now become the dominant strain in the U.S., the head of the Centers for Disease Control and Prevention said Wednesday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

NIH launches study to gauge risk of allergic reactions to Pfizer, Moderna vaccines

The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UK advises limiting AstraZeneca in under-30s amid clot issue

OPINION: CDC has public health messaging problems about the Covis pandemic

ANALYSIS: Why COVIDF-19 conspiracy theories persist

As the world struggles to break the grip of COVID-19, psychologists and misinformation experts are studying why the pandemic spawned so many conspiracy theories, which have led people to eschew masks, social distancing and vaccines.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

‘Vaccine Passports’ Emerge as the Next Coronavirus political Divide, White House aloof

...Around the country, businesses, schools and politicians are considering “vaccine passports” — digital proof of vaccination against the coronavirus — as a path to reviving the economy and getting Americans back to work and play. Businesses especially fear that too many customers will stay away unless they can be assured that the other patrons have been inoculated.

But the idea is raising charged legal and ethical questions: Can businesses require employees or customers to provide proof — digital or otherwise — that they have been vaccinated when the coronavirus vaccine is ostensibly voluntary?

Problem, Solution, SitRep, or ?: 

AstraZeneca's coronavirus vaccine plausibly linked to rare brain clots, European regulators say

Pages

Subscribe to Global RSS
howdy folks
Page loaded in 1.031 seconds.